0001596771-18-000020.txt : 20180212
0001596771-18-000020.hdr.sgml : 20180212
20180212164047
ACCESSION NUMBER: 0001596771-18-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180208
FILED AS OF DATE: 20180212
DATE AS OF CHANGE: 20180212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reno Seth
CENTRAL INDEX KEY: 0001674004
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 18597072
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gemphire Therapeutics Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
BUSINESS PHONE: 248-980-6538
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-02-08
0
0001638287
Gemphire Therapeutics Inc.
GEMP
0001674004
Reno Seth
17199 N. LAUREL PARK DRIVE
SUITE 401
LIVONIA
MI
48152
0
1
0
0
Chief Commercial Officer
Common Stock
2018-02-08
4
P
0
14286
7
A
18286
D
The shares were purchased in a confidentially marketed public offering pursuant to an Underwriting Agreement. The offering closed on February 12, 2018.
/s/ Stephanie Swan, by Power of Attorney
2018-02-12